August 20-22, 2026 | 25 CME | Palm Springs, California

CE/CME Accreditation

Earn up to 25 CME credits at IDS 2025 by completing 14 CME credits through pre-conference on-demand courses and 10 CME credits in person, plus 1 credit from the CEA-hosted session “Psoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management” on August 21 at 5:30 PM.

Accreditation Statement

The 2026 Integrative Dermatology Symposium is pending approval for 25 credits of continuing medical education (CME) by Medical Education Resources, Inc. 14 CME credits in person and access an additional 11 CME credits online.

 
ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and LearnHealth. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
PHYSICIAN CREDIT
Medical Education Resources designates this live activity for a maximum of 25 AMA PRA Category 1 Credits™. Physicians should claim the credit commensurate with the extent of their participation in the activity. (Pending approval)
 
 
PHYSICIAN ASSOCIATE CREDIT 

Medical Education Resources has been authorized by the American Academy of Physician Associate (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 25 AAPA Category 1 CME Credits. Physician Associate should only claim credit commensurate with the extent of their participation. (Pending Approval)

NURSING CREDIT

Medical Education Resources designates this live activity for a maximum of 25 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 25 contact hours. (Pending approval)

FOR NATUROPATHIC DOCTORS

The Integrative Dermatology Symposium is pending approval for 25 General credit(s) of continuing education credits by the American Association of Naturopathic Physicians.

As you know, CE approval by the AANP covers all states that regulate naturopathic physicians, except Oregon. Please note that as of January 2025, the Oregon Board of Naturopathic Medicine (OBNM) will no longer approve a CE Activity submitted to them by the CE Activity Host. Only the individual Oregon licensee can apply directly to OBNM for CE approval.

If you do have an Oregon licensed ND attend your event, you can notify them that the program has not been submitted for approval to the OBNM, and provide them with the information needed for them to apply for approval as an individual. The AANP can assist you with providing Oregon NDs the requisite materials. (Pending approval)

 
 
FOR ACUPUNCTURISTS AND ORIENTAL MEDICINE PRACTITIONERS
The Integrative Dermatology Symposium is pending approval by the National Certification Commission for Acupuncture and Oriental Medicine and is applying for 25 PDA Points. NCCAOM® PDA Points Provider #9093. (Pending approval)
 

Goal & Purpose

The annual Integrative Dermatology Symposium is designed to appeal to practitioners across disciplines. It will address emerging trends, and practical approaches to dermatology as practitioners assess and manage skin conditions and care. It is estimated that nearly one-third of the population is afflicted with a skin disorder. There is a great need for best practice sharing and cross-collaboration to support practitioners in the field and improve patient outcomes.

Target Audience

This live symposium is designed to meet the educational needs of:

Disclosure of relevant financial relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
 
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity
Name of Faculty
Reported Financial Relationship
Anil Bajnath, MD MBA IFMCP
Anil Bajnath

MD

No financial relationships to disclose.

Neal Bhatia

MD

Consulting Fees (e.g. Advisory Board) Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Grants/Research Support Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Honorarium Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Speakers’ Bureau Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Amy Branum

AHP RH (AGH)

No financial relationships to disclose.

Ganary Dabiri

MD PhD

Consulting Fees (e.g. Advisory Board)

Leo pharmaceutical. jansen, Eli Lilly, Galderma

Patricia Delgado

DNP, AGPCNP, DCNP, PMHNP

Consulting Fees (e.g. Advisory Board)
ReachRx, MJH LifeSciences, Novartis

Larry Eichenfield

MD

Consulting Fees (e.g. Advisory Board)

Abbvie Abeona Acrotech Amgen Almirall Apogee Arcutis Attovia Bausch Bristol-Myers Squib Corevitas Dermata Dermavant

Formation Bio Forte Galderma Incyte Janssen Kenvue Krystal Kymera LEO Lilly Novartis OrthoDerm Pfizer Regeneron Sanofi T-Rex

Takeda Union Therapeutics UCB Verrica

Employee / Owner Verrica – Board of Directors, not employee 

Grants/Research Support Abbvie Amgen Arcutis Bausch Castle Biosciences Dermavant Galderma Incyte Pfizer Target RWE 

Ownership Interest / Stock Holder Dermata, Forte – (Options), Verrica – (Options) 

Speakers’ Bureau Dermavant, Incyte, LEO, Lilly, OrthoDerm, Pfizer, Regeneron, Sanofi,

Lakshi Alderdge, MSN ANP-BC DCNP FAANP
Lakshi Aldredge

NP

Consulting Fees (e.g. Advisory Board)
AbbVie, Arcutis, BMS, Boehringer Ingelheim, Regeneron, Sanofi, Pfizer, J&J, Novartis, Galderma, Leo Pharma, Sun Pharma, UCB,
Incyte, Takeda

Honorarium MedScape, PeerView

Speakers’ Bureau Regeneron, Sanofi, Johnson&Johnson, Sun Pharma, Galderma, UCB, Leo Pharma

Francesca Lewis

MD

Consulting Fees (e.g. Advisory Board)

Galderma, Allergan, Acclaro

Speakers’ Bureau Galderma, Allergan, Acclaro

Jesse Schwartzberg

MD

No financial relationships to disclose.

James Song, MD
James Song

MD

Consulting Fees (e.g. Advisory Board)
AbbVie, Alumis, Alphyn, Amgen, Apogee, Arcutis, BMS, Boehringer-Ingelheim, Dermavant/Organon, DermBiont, Galderma, Incyte,
Johnson&Johnson, LEO, Novartis, Ortho-dermatologics, Pfizer, Phothera, Sanofi & Regeneron, SUN, UCB, Takeda

Grants/Research Support AbbVie, Alumis, Amgen, Apogee, Arcutis, BMS, DermBiont, Incyte, Johnson & Johnson, LEO, MoonLake, Pfizer, Veradermics, Sanofi, SUN, TIMBER, Zura Bio

Honorarium AbbVie, Alumis, Alphyn, Amgen, Apogee, Arcutis, BMS, Boehringer-Ingelheim, Dermavant/Organon, DermBiont, Galderma, Incyte, Johnson&Johnson, LEO, Novartis, Ortho-dermatologics, Pfizer, Phothera, Sanofi & Regeneron, SUN, UCB, Takeda

Speakers’ Bureau AbbVie,,, Amgen,, Arcutis,BMS, Dermavant/Organon, Galderma, Incyte, Johnson&Johnson, LEO, Novartis, Ortho-dermatologics, Pfizer, Phothera, Sanofi & Regeneron, SUN, UCB

Michael-Traub ND DHANP FABNO
Michael Traub

ND

Consulting Fees (e.g. Advisory Board) NeoGenesis, LearnSkin, Kamedis, Nutritional Fundamentals for Health

Naiem Issa

MD, PhD

Consulting Fees (e.g. Advisory Board)
Almirall, Apogee, Bristol Myers Squibb, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Novartis, Organon, Ortho Dermatologics, Oruka, Pfizer, Primus, Regeneron, Sanofi, SUN Pharmaceuticals Industry, UCB

Grants/Research Support
Lilly, Novartis

Honorarium
Abbvie, Almirall, Boehringer Ingelheim, Botanix, Bristol Myers Squibb, Galderma, Incyte, Journey, LEO Pharma, Lilly, Novartis, Organon, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, SUN Pharmaceuticals Industry, Topix, UCB

Speakers’ Bureau
Abbvie, Almirall, Boehringer Ingelheim, Botanix, Bristol Myers Squibb, Galderma, Incyte, Journey, LEO Pharma, Lilly, Novartis, Organon, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, SUN Pharmaceuticals Industry, Topix, UCB

Neal Bhatia

MD

Consulting Fees (e.g. Advisory Board) Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Grants/Research Support Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Honorarium Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Speakers’ Bureau Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Alumis, Apogee, Arcutis, Avene, Biofrontera, Blueprint, Celldex, Galderma, Highlight, InCyte, J&J, Journey, LaRoche-Posay, LEO, Lilly, NAOS, Novartis, Ortho, Oruka, Pelthos, Pfizer, Regeneron, Sagimet, Sanofi, SkinFix, Soligenix, SunPharma, Takeda, Veradermics, and Verrica

Patricia Delgado

DNP, AGPCNP, DCNP, PMHNP

Consulting Fees (e.g. Advisory Board)
ReachRx, MJH LifeSciences, Novartis

Peter Lio

MD

Ownership Interest / Stock Holder
Stock options only: Alphyn Labs, Codex Labs, Concerto Biosci, Thimble, Yobee Care

Royalty / Patent Holder
Theraplex AIM

Speakers’ Bureau
AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, MyOR Diagnostics, Pfizer, Pierre-Fabre
Dermatologie, Regeneron/Sanofi Genzyme, Verrica

Pooja Shah

MD

Consulting Fees (e.g. Advisory Board)
Advisory Board – Sanofi Genzyme; Advisory Board – Incyte; Advisory Board – Castle Biosciences Inc; Consulting – RTI International

Honorarium
Honorarium – Society of Dermatology Nurse Practitioners (SDNP)

Sonal Choudary

MD

Grants/Research Support
Eli Lilly

Speakers’ Bureau
Regeneron/Sanofi

Whitney High

MD, JD, MEng

No financial relationships to disclose.

Raja Sivamani, MD MS AP
Raja Sivamani

MD, JD, MEng

Consulting Fees (e.g. Advisory Board)
Arbonne; Codex Labs; Burt’s Bees; Nutraceutical Wellness; Arcutis; Regeneron Pharmaceuticals; Janssen; Leo Pharma

Honorarium
Bristol Myers Squibb; Blueprint Medicines; Incyte; Galderma; Amgen; Almirall; Trace Minerals; AbbVie; UCB; Sun Pharmaceuticals; Pfizer; Phothera; Regeneron Pharmaceuticals; Janssen; Novartis; Eli Lilly

Speakers’ Bureau
Bristol Myers Squibb; Incyte; Galderma; Almirall; AbbVie; Leo Pharma; UCB; Sun Pharmaceuticals; Pfizer; Phothera; Regeneron Pharmaceuticals; Janssen; Eli Lilly

Sandra Chiu

L.Ac., DACM

No financial relationships to disclose.

Jennifer Soung

MD

No financial relationships to disclose.

Jennifer Soung

MD

Consulting Fees (e.g. Advisory Board)
AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Boehringer Ingelheim, Dermavant, Eli Lilly, Galderma, Incyte, Johnson & Johnson, KoBio Labs, LEO, Novartis, Ortho Dermatologics, Pelthos, Pfizer, Regeneron, Sanofi, and UCB.

Grants/Research Support
AbbVie, Arcutis, Dermavant, Eli Lilly, Johnson & Johnson, Novartis, Oruka, Pfizer, Sanofi, and UCB

Honorarium
AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Eli Lilly, Incyte, Johnson & Johnson, Ortho Dermatologics, Pelthos, Pfizer, Regeneron, Sanofi.

Ownership Interest / Stock Holder
Pfizer

Royalty / Patent Holder
NA

Speakers’ Bureau
AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Eli Lilly, Incyte, Johnson & Johnson, Ortho Dermatologics, Pelthos, Pfizer, Regeneron, Sanofi.

Aric Prather

PhD

Grants/Research Support
Eisai, Lt Co.; Big Health, Ltd

Daniel Butler

MD

Grants/Research Support
Abbive, Pfizer, Incyte

Speakers’ Bureau
Leo, Sanofi, Lilly, Galderma

Sahar Swidan

PharmD

Consulting Fees (e.g. Advisory Board)
A4M-Faculty-Director of Professional Education

Employee / Owner
NeuroPharm-Consulting Company

Diana Hurwitz

MD

No financial relationships to disclose.

Stacy McClure MD
Stacy Mc Clure

MD

No financial relationships to disclose.

Glynis Ablon

MD

Grants/Research Support
Galderma, Bausch, Church Dwight, Everwell, Veradermics

Jennifer Ornelas

MD

Consulting Fees (e.g. Advisory Board)
Advisory Board- Leo pharma, Organon, and Sanofi

Speakers’ Bureau
Organon

Heather Woolery-Lloyd

MD

Consulting Fees (e.g. Advisory Board)
Nutrafol, Ortho Dermatologics, AbbVie, Incyte, L’Oréal, Arcutis, Johnson & Johnson, Kenvue, Galderma, Unilever

Grants/Research Support
Nordberg Medical, Kymera, AbbVie, Allergan, Eirion Therapeutics, Regeneron, Galderma, Pfizer, Arcutis, Teoxane Laboratories, Avita Medical

Edward (Ted) Lain

Consulting Fees (e.g. Advisory Board)
AbbVie (Consultant) Allergan, Inc. (Advisory Board) Allergan, Inc. (Speaker/Faculty Education – Fees) Almirall (Advisory Board) Almirall (Consultant) Beiersdorf, Inc. (Advisory Board) Biofrontera (Advisory Board) Bristol Myers Squibb (Advisory Board) Bristol Myers Squibb (Consultant) Bristol-Myers Squibb (Speaker – Fees) Cutera, Inc. (Consultant) (2 relationships) Dermavant Sciences, Inc. (Advisory Board) Eli Lilly (Advisory Board) Eli Lilly and Company (Consultant) Estée Lauder (Consultant) Galderma USA (Advisory Board) Incyte (Advisory Board) Incyte (Consultant) Janssen (Advisory Board) L’Oréal (Consultant) Menlo Therapeutics (Advisory Board) Novartis (Advisory Board) Ortho Dermatologics (Advisory Board) Ourself (Consultant) Pfizer Inc. (Advisory Board) Sente Labs (Consultant) SkinCeuticals LLC (Advisory Board) Sun Pharmaceutical Industries Ltd. (Advisory Board) Takeda Pharmaceuticals USA Inc. (Advisory Board) UCB (Consultant)

Grants/Research Support
AbbVie, Aclaris Therapeutics Inc., AiViva BioPharma, Inc., Allergan, Inc., Arcutis Biotherapeutics, ASLAN Pharmaceuticals, AstraZeneca, Athenix, Biofrontera, BMS, Brickell Biotech, Inc., Cassiopea S.p.A., Celgene, Cellceutix, Celldex, Concert Pharmaceuticals, Dermavant Sciences, Inc., Dow Pharmaceutical Sciences, Inc., Dr. Reddy’s Laboratory, Eli Lilly and Company, Galderma Laboratories, L.P., Galderma USA, Highlightll Pharmaceutical, Incyte Corporation, Janssen, Kadmon Corporation, LLC, LEO Laboratories Ltd., MedImmune, Menlo Therapeutics, Nektar Therapeutics, Neothetics, Nielsen Holdings N.V., Novartis, Ortho Dermatologics, Pfizer Inc., Q32 Bio Inc., Regenx, Sebacia, Inc. (2 relationships), Soligenix, Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceuticals USA Inc., TEOXANE Laboratories, UCB, Valeant Pharmaceuticals North America LLC, Vanda Pharmaceuticals Inc., Verrica Pharmaceuticals Inc.

Honorarium
Aclaris Therapeutics Inc. Almirall Arcutis, Inc. Dermavant Sciences, Inc. Eli Lilly Galderma Laboratories, L.P. Incyte Corporation La Roche-Posay Laboratorie Ortho Dermatologics Pfizer Inc. Promius Pharma, LLC SkinCeuticals LLC

Ownership Interest / Stock Holder
Moleculin LLC (Stockholder)

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager
Reported Financial Relationship
Venita Sivamani
Venita Sivamani

LearnHealth Inc. Stockholder

Mer Content Manager

No financial relationships to disclose.

Course Participant Attestation

I understand that the information in this course presented by the Provider and/orInstructor(s) is for educational purposes only and should only be applied with appropriate clinical judgment and used by a trained and licensed practitioner. Governmental laws and regulations vary from region to region and the contents of this course vary in permissible usage. The participant is required to check their local, state, and federal laws and regulations regarding the practice requirements and scope of practice issues and the use of the information of this course including, but not limited to, theory, herbal medicine, and acupuncture. I acknowledge that NCCAOM does not endorse any specific treatment regimens of any kind. Furthermore, if I use any modalities or treatments taught in this course, I agree to waive, release, indemnify, discharge, and covenant not to sue NCCAOM from and against any liability, claims, demands, or causes of action whatsoever, arising out of any injury, loss, or damage that a person may sustain related to the use of the information in this course. I understand that this Release is governed by the laws of District of Columbia, U.S.A. and shall survive the termination or expiration of this course.

DISCLAIMER

The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of MER and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Join The List

Sign up to receive exclusive discounts and special offers

One Week. Two Events.

Save 15% on IDS and IAS registration with code JULY4 through July 10.
Days
Hours
Minutes
Seconds

BEST PRICING ENDS SOON